Sykehusinnkjøp HF 916879067 Postboks 40 Vadsø 9811 Carola Marie Sommevåg carola.marie.sommevag@sykehusinnkjop.no https://permalink.mercell.com/88262016.aspx http://www.sykehusinnkjop.no/ LIS 2018 Rituksimab - Intention notice 2017/715 Sykehusinnkjøp HF, Medicines Division - LIS, intends to enter into a contract for Rituksimab L01XC02, Subuctan formulation between Roche Norge AS and Helse Nord RHF, Helse Midt-Norge RHF, Helse Sør-Øst RHF and Helse Vest RHF from 1.8.2018 to 31.1.2019. See the annex. 50000000.00 Sykehusinnkjøp HF, Medicines Division - LIS, intends to enter into a contract for rituksimab L01XC02, Subuctan formulation between Roche Norge AS and Helse Nord RHF, Helse Midt-Norge RHF, Helse Sør-Øst RHF and Helse Vest RHF from 1.8.2018 to 31.1.2019. The turnover on the contract is estimated to 50 000 000 NOK for a contract period of 9 months, based on historical consumption. See the annex. Sykehusinnkjøp HF, Medicines Division - LIS, intends to enter into a contract for rituksimab L01XC02, between Roche Norge AS and Helse Nord RHF, Helse Midt-Norge RHF, Helse Sør-Øst RHF and Helse Vest RHF from 1.8.2018 to 31.1.2019. This applies to the following product numbers: — 545104 MabThera inj 1400mg/hgl 11,7 MLHGL L01XC02 — 393838 MabThera inj 1600mg/hgl 13,4 MLHGL L01XC02 See the regulations §21-5 and §13-4 letter b nº 3 if there are no reasonable alternatives. 2018 RHF Rituksimab 2018 RHF Rituksimab 2018-07-02 Roche Norge AS 935 925 525 Brynsengfaret 6B Oslo 0667 50000000.00 Sykehusinnkjøp HF, divisjon legemidler Grev Wedels plass 7 Oslo 0151 legemidler@sykehusinnkjop.no http://sykehusinnkjop.no Klagenemda for offentlige anskaffelser Postboks 439 Sentrum Bergen 5805 +47 55597500 postmottak@kofa.no +47 55597599 http://www.kofa.no Sykehusinnkjøp HF, divisjon legemidler Grev Wedels plass 7 Oslo 0151 legemidler@sykehusinnkjop.no http://sykehusinnkjop.no 2018-07-03
See tender at TED: http://ted.europa.eu/udl?uri=TED:NOTICE:288584-2018:TEXT:EN:HTML